Banque Cantonale Vaudoise Organon & Co. Transaction History

Banque Cantonale Vaudoise

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$16.59 - $23.77 $1,194 - $1,711	-72 Reduced 37.89%	118 $2,000
Q3 2022 Oct 17, 2022	SELL	$23.4 - $34.25 $5,405 - $7,911	-231 Reduced 54.87%	190 $4,000
Q2 2022 Aug 02, 2022	SELL	$31.66 - $38.9 $103,179 - $126,775	-3,259 Reduced 88.56%	421 $14,000
Q1 2022 May 09, 2022	SELL	$30.45 - $39.36 $5,146 - $6,651	-169 Reduced 4.39%	3,680 $128,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $49,541 - $64,160	1,728 Added 81.47%	3,849 $117,000
Q3 2021 Oct 29, 2021	SELL	$28.63 - $35.64 $37,734 - $46,973	-1,318 Reduced 38.33%	2,121 $69,000
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $97,839 - $130,682	3,439 New	3,439 $104,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.